Search Results 7101-7110 of 26610 for oral
Oral gonadotropin-releasing hormone antagonists for the treatment of uterine leiomyomas. Obstetrics & Gynecology. 2023; doi:10.1097/AOG.0000000000005145 ...
NOTE: Patients who have received acute, low-dose systemic steroids (≤ 10 mg/day oral prednisone or equivalent) prior to registration or a one-time pulse ...
... oral contraceptives are also used. All subjects of reproductive potential must agree to use both a barrier method and a second method of birth control ...
Patient is unable to take drugs orally due to disorders or diseases that may affect gastrointestinal function, such as inflammatory bowel diseases (e.g. ...
Patients must have the ability to swallow and retain oral medication; Absolute neutrophil count (ANC) must be >= 1200/mm^3; Platelet count must be >= 100,000 ...
Able to swallow oral formulation of the study agent; Hemoglobin >= 9 g/dL; Platelet count >= 75,000/mm^3; Creatinine =< 1.5 x upper limits of normal (ULN) ...
Gastrointestinal (GI) tract disease that causes an inability to take oral medications, malabsorption syndrome, prior surgical procedures affecting ...
Olson, M.D., M.S.. Rochester, MN. Areas of focus: Facial fracture repair, Rhinoplasty, Oral surgery, Face lift, Glossectomy, Nasal valve repair, Tonsillectomy ...
Must be able to swallow an oral medication. Must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. Patient agrees to use ...
Oral contraceptive, either combined or progestogen alone;; Contraceptive subdermal implant (e.g., Norplant®);; Injectable progestogen (e.g., Depo-Provera ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.